
GlaxoSmithKline Pharmaceuticals Limited announced the appointment of Manu Anand as Additional Director on the Board of the company, with effect from May 16, 2022. According to the company’s exchange filing, “Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that Board of…